Product Name

  • Name

    Arecoline hydrobromide

  • EINECS 206-087-3
  • CAS No. 300-08-3
  • Article Data1
  • CAS DataBase
  • Density
  • Solubility 0.1 g/mL in water
  • Melting Point 171-175 °C
  • Formula C8H14BrNO2
  • Boiling Point 209 °C at 760 mmHg
  • Molecular Weight 236.109
  • Flash Point 81.1 °C
  • Transport Information
  • Appearance white fine powder
  • Safety 45-38-36/37/39-28A
  • Risk Codes 22-23/24/25
  • Molecular Structure Molecular Structure of 300-08-3 (Arecoline hydrobromide)
  • Hazard Symbols HarmfulXn, ToxicT
  • Synonyms 3-Pyridinecarboxylicacid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester, hydrobromide (9CI);Nicotinicacid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester, hydrobromide (8CI);Arecolinebromide;
  • PSA 29.54000
  • LogP 1.31730

Synthetic route

arecoline hydrobromide
300-08-3

arecoline hydrobromide

arecoline
63-75-2

arecoline

Conditions
ConditionsYield
With potassium carbonate In dichloromethane; water at 20℃; for 0.5h;100%
With sodium carbonate pH=10 - 11; deprotonation;
With water; sodium carbonate for 0.5h;
With sodium hydroxide; water In ethyl acetate
With sodium carbonate In water pH=13 - 14;
arecoline hydrobromide
300-08-3

arecoline hydrobromide

methyl iodide
74-88-4

methyl iodide

N-Methylarecolinium iodide
4554-30-7

N-Methylarecolinium iodide

Conditions
ConditionsYield
In diethyl ether96%
arecoline hydrobromide
300-08-3

arecoline hydrobromide

benzenesulfonyl chloride
98-09-9

benzenesulfonyl chloride

methyl 1-benzenesulfonyl-1,2,5,6-tetrahydropyridine-3-carboxylate
929803-75-8

methyl 1-benzenesulfonyl-1,2,5,6-tetrahydropyridine-3-carboxylate

Conditions
ConditionsYield
Multistep reaction;90%
arecoline hydrobromide
300-08-3

arecoline hydrobromide

1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid
499-04-7

1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid

Conditions
ConditionsYield
Stage #1: arecoline hydrobromide With sodium carbonate In water pH=10 - 11;
Stage #2: With water Reflux;
89%
With barium dihydroxide at 40℃; for 0.5h;
Multi-step reaction with 2 steps
1: aq. Na2CO3 / pH 10 - 11
2: 8.2 g / water / 24 h / Heating
View Scheme
With hydrogenchloride; water Heating / reflux;
arecoline hydrobromide
300-08-3

arecoline hydrobromide

phenylmagnesium bromide
100-58-3

phenylmagnesium bromide

1-Methyl-4-phenyl-piperidine-3-carboxylic acid methyl ester
53757-41-8

1-Methyl-4-phenyl-piperidine-3-carboxylic acid methyl ester

Conditions
ConditionsYield
Stage #1: arecoline hydrobromide With sodium hydride In toluene at -10℃; for 0.25h;
Stage #2: phenylmagnesium bromide In diethyl ether; toluene at -10℃; for 1h;
83%
benzyl bromide
100-39-0

benzyl bromide

arecoline hydrobromide
300-08-3

arecoline hydrobromide

1-Benzyl-5-methoxycarbonyl-1-methyl-1,2,3,6-tetrahydro-pyridinium; bromide

1-Benzyl-5-methoxycarbonyl-1-methyl-1,2,3,6-tetrahydro-pyridinium; bromide

Conditions
ConditionsYield
In nitromethane77%
arecoline hydrobromide
300-08-3

arecoline hydrobromide

phenyl chloroformate
1885-14-9

phenyl chloroformate

3-methoxycarbonyl-1-phenoxycarbonyl-1,2,5,6-tetrahydropyridine
323201-17-8

3-methoxycarbonyl-1-phenoxycarbonyl-1,2,5,6-tetrahydropyridine

Conditions
ConditionsYield
Stage #1: arecoline hydrobromide With sodium hydrogencarbonate
Stage #2: phenyl chloroformate In dichloromethane at 0 - 20℃; for 24h;
76%
With sodium hydrogencarbonate In dichloromethane at 0 - 20℃; for 24h;
arecoline hydrobromide
300-08-3

arecoline hydrobromide

propyl bromide
106-94-5

propyl bromide

5-Methoxycarbonyl-1-methyl-1-propyl-1,2,3,6-tetrahydro-pyridinium; bromide

5-Methoxycarbonyl-1-methyl-1-propyl-1,2,3,6-tetrahydro-pyridinium; bromide

Conditions
ConditionsYield
In nitromethane47%
(S,S)-hydrobenzoin
2325-10-2

(S,S)-hydrobenzoin

arecoline hydrobromide
300-08-3

arecoline hydrobromide

(1S,2S)-(-)-2-hydroxy-1,2-diphenylethyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate

(1S,2S)-(-)-2-hydroxy-1,2-diphenylethyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate

Conditions
ConditionsYield
Stage #1: arecoline hydrobromide With sodium carbonate In water
Stage #2: (S,S)-hydrobenzoin With potassium tert-butylate In toluene for 16h; Reflux; Molecular sieve; stereoselective reaction;
22%
hydroxyguanidine hemisulfate hemihydrate
6345-29-5

hydroxyguanidine hemisulfate hemihydrate

arecoline hydrobromide
300-08-3

arecoline hydrobromide

3-(3-amino-1,2,4-oxadiazol-5-yl)-1-methyl-1,2,5,6-tetrahydropyridine
114724-86-6

3-(3-amino-1,2,4-oxadiazol-5-yl)-1-methyl-1,2,5,6-tetrahydropyridine

Conditions
ConditionsYield
With 4 A molecular sieve; sodium In ethanol 1.) 20 deg C, 0.5 h, 2.) reflux, 0.5 h;17%
(1S,2R)-1,2-diphenylethane-1,2-diol
579-43-1

(1S,2R)-1,2-diphenylethane-1,2-diol

arecoline hydrobromide
300-08-3

arecoline hydrobromide

rac-(1S,2R)-2-hydroxy-1,2-diphenylethyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate

rac-(1S,2R)-2-hydroxy-1,2-diphenylethyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate

Conditions
ConditionsYield
Stage #1: arecoline hydrobromide With sodium carbonate In water
Stage #2: (1S,2R)-1,2-diphenylethane-1,2-diol With potassium tert-butylate In toluene for 16h; Reflux; Molecular sieve; stereoselective reaction;
16%
phosgene
75-44-5

phosgene

arecoline hydrobromide
300-08-3

arecoline hydrobromide

(N-chlorocarbonyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid methyl ester)
121661-86-7

(N-chlorocarbonyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid methyl ester)

Conditions
ConditionsYield
In toluene
N'-hydroxypivalimidamide
42956-75-2

N'-hydroxypivalimidamide

arecoline hydrobromide
300-08-3

arecoline hydrobromide

5-(3-tert-Butyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine
131865-05-9

5-(3-tert-Butyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine

Conditions
ConditionsYield
With 4 A molecular sieve; sodium 1.) ethanol, RT, 10 min, 2.) ethanol, 80 deg C, 12 h; Multistep reaction;
3-methoxypropionamide oxime
77072-12-9

3-methoxypropionamide oxime

arecoline hydrobromide
300-08-3

arecoline hydrobromide

5-[3-(2-Methoxy-ethyl)-[1,2,4]oxadiazol-5-yl]-1-methyl-1,2,3,6-tetrahydro-pyridine
123686-54-4

5-[3-(2-Methoxy-ethyl)-[1,2,4]oxadiazol-5-yl]-1-methyl-1,2,3,6-tetrahydro-pyridine

Conditions
ConditionsYield
With 4 A molecular sieve; sodium 1.) ethanol, RT, 10 min, 2.) ethanol, 80 deg C, 12 h; Multistep reaction;
hexanamide oxime
108724-16-9

hexanamide oxime

arecoline hydrobromide
300-08-3

arecoline hydrobromide

1-Methyl-5-(3-pentyl-[1,2,4]oxadiazol-5-yl)-1,2,3,6-tetrahydro-pyridine
114905-01-0

1-Methyl-5-(3-pentyl-[1,2,4]oxadiazol-5-yl)-1,2,3,6-tetrahydro-pyridine

Conditions
ConditionsYield
With 4 A molecular sieve; sodium 1.) ethanol, RT, 10 min, 2.) ethanol, 80 deg C, 12 h; Multistep reaction;
N'-hydroxypentanimidamide
67015-06-9

N'-hydroxypentanimidamide

arecoline hydrobromide
300-08-3

arecoline hydrobromide

1-methyl-3-(3-butyl-1,2,4-oxadiazol-5-yl)-1,2,5,6-tetrahydropyridine
114904-63-1

1-methyl-3-(3-butyl-1,2,4-oxadiazol-5-yl)-1,2,5,6-tetrahydropyridine

Conditions
ConditionsYield
With 4 A molecular sieve; sodium 1.) ethanol, RT, 10 min, 2.) ethanol, 80 deg C, 12 h; Multistep reaction;
isobutyramide oxime
35613-84-4

isobutyramide oxime

arecoline hydrobromide
300-08-3

arecoline hydrobromide

5-(3-Isopropyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine
114904-61-9

5-(3-Isopropyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine

Conditions
ConditionsYield
With 4 A molecular sieve; sodium 1.) ethanol, RT, 10 min, 2.) ethanol, 80 deg C, 12 h; Multistep reaction;
cyclopropanecarboxamide oxime
51285-13-3

cyclopropanecarboxamide oxime

arecoline hydrobromide
300-08-3

arecoline hydrobromide

5-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine
114904-31-3

5-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine

Conditions
ConditionsYield
With 4 A molecular sieve; sodium 1.) ethanol, RT, 10 min, 2.) ethanol, 80 deg C, 12 h; Multistep reaction;
arecoline hydrobromide
300-08-3

arecoline hydrobromide

N'-hydroxy-2-methoxyethanimidamide
95298-88-7

N'-hydroxy-2-methoxyethanimidamide

5-(3-Methoxymethyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine
114904-32-4

5-(3-Methoxymethyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine

Conditions
ConditionsYield
With 4 A molecular sieve; sodium 1.) ethanol, RT, 10 min, 2.) ethanol, 80 deg C, 12 h; Multistep reaction;
arecoline hydrobromide
300-08-3

arecoline hydrobromide

3-Ethoxy-N'-hydroxypropanimid amide

3-Ethoxy-N'-hydroxypropanimid amide

5-[3-(2-Ethoxy-ethyl)-[1,2,4]oxadiazol-5-yl]-1-methyl-1,2,3,6-tetrahydro-pyridine
123686-56-6

5-[3-(2-Ethoxy-ethyl)-[1,2,4]oxadiazol-5-yl]-1-methyl-1,2,3,6-tetrahydro-pyridine

Conditions
ConditionsYield
With 4 A molecular sieve; sodium 1.) ethanol, RT, 10 min, 2.) ethanol, 80 deg C, 12 h; Multistep reaction;
arecoline hydrobromide
300-08-3

arecoline hydrobromide

2-cyclopropyl-N'-hydroxyethanimidamide
152821-00-6

2-cyclopropyl-N'-hydroxyethanimidamide

5-(3-Cyclopropylmethyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine
131865-07-1

5-(3-Cyclopropylmethyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine

Conditions
ConditionsYield
With 4 A molecular sieve; sodium 1.) ethanol, RT, 10 min, 2.) ethanol, 80 deg C, 12 h; Multistep reaction;
arecoline hydrobromide
300-08-3

arecoline hydrobromide

octanamide oxime
114878-45-4

octanamide oxime

5-(3-Heptyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine
114905-03-2

5-(3-Heptyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine

Conditions
ConditionsYield
With 4 A molecular sieve; sodium 1.) ethanol, RT, 10 min, 2.) ethanol, 80 deg C, 12 h; Multistep reaction;
arecoline hydrobromide
300-08-3

arecoline hydrobromide

n-nonanamidoxime
103499-15-6

n-nonanamidoxime

1-Methyl-5-(3-octyl-[1,2,4]oxadiazol-5-yl)-1,2,3,6-tetrahydro-pyridine
114904-99-3

1-Methyl-5-(3-octyl-[1,2,4]oxadiazol-5-yl)-1,2,3,6-tetrahydro-pyridine

Conditions
ConditionsYield
With 4 A molecular sieve; sodium 1.) ethanol, RT, 10 min, 2.) ethanol, 80 deg C, 12 h; Multistep reaction;
arecoline hydrobromide
300-08-3

arecoline hydrobromide

N-hydroxycyclobutanecarboxamidine
99623-08-2

N-hydroxycyclobutanecarboxamidine

5-(3-Cyclobutyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine
123686-50-0

5-(3-Cyclobutyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine

Conditions
ConditionsYield
With 4 A molecular sieve; sodium 1.) ethanol, RT, 10 min, 2.) ethanol, 80 deg C, 12 h; Multistep reaction;
arecoline hydrobromide
300-08-3

arecoline hydrobromide

N-hydroxycyclopentanecarboxamidine
99623-12-8

N-hydroxycyclopentanecarboxamidine

5-(3-Cyclopentyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine
123686-52-2

5-(3-Cyclopentyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine

Conditions
ConditionsYield
With 4 A molecular sieve; sodium 1.) ethanol, RT, 10 min, 2.) ethanol, 80 deg C, 12 h; Multistep reaction;
arecoline hydrobromide
300-08-3

arecoline hydrobromide

N-hydroxy-cycloheptanecarboximidamide

N-hydroxy-cycloheptanecarboximidamide

5-(3-Cycloheptyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine
131865-06-0

5-(3-Cycloheptyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine

Conditions
ConditionsYield
With 4 A molecular sieve; sodium 1.) ethanol, RT, 10 min, 2.) 80 deg C, 12 h; Multistep reaction;
arecoline hydrobromide
300-08-3

arecoline hydrobromide

3-methyl-5-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,4-oxadiazole
114724-56-0

3-methyl-5-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,4-oxadiazole

Conditions
ConditionsYield
With 4 A molecular sieve; sodium 1.) ethanol, RT, 10 min, 2.) 80 deg C, 12 h; Multistep reaction;
arecoline hydrobromide
300-08-3

arecoline hydrobromide

N-hydroxypropanimidamide
29335-36-2

N-hydroxypropanimidamide

5-(3-Ethyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine
114904-48-2

5-(3-Ethyl-[1,2,4]oxadiazol-5-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine

Conditions
ConditionsYield
With 4 A molecular sieve; sodium 1.) ethanol, RT, 10 min, 2.) ethanol, 80 deg C, 12 h; Multistep reaction;
arecoline hydrobromide
300-08-3

arecoline hydrobromide

butyramide oxime
27620-10-6

butyramide oxime

1-Methyl-5-(3-propyl-[1,2,4]oxadiazol-5-yl)-1,2,3,6-tetrahydro-pyridine
114904-46-0

1-Methyl-5-(3-propyl-[1,2,4]oxadiazol-5-yl)-1,2,3,6-tetrahydro-pyridine

Conditions
ConditionsYield
With 4 A molecular sieve; sodium 1.) ethanol, RT, 10 min, 2.) ethanol, 80 deg C, 12 h; Multistep reaction;

Arecoline hydrobromide Chemical Properties

IUPAC NAME: Methyl 1-methyl-3,6-dihydro-2H-pyridine-5-carboxylate hydrobromide
EINECS: 206-087-3
Molecular Formula: C8H14BrNO2
Molecular Weight: 236.11 g/mol
Melting Point: 171-175 °C
Flash Point: 81.1 °C
Boiling Point: 209 °C at 760 mmHg
Molecule structure of Arecoline hydrobromide (CAS NO.300-08-3):

   
Solubility H2O: 0.1 g/mL, clear, colorless
H-Bond Acceptor: 3
Rotatable Bond Count: 2
Exact Mass: 235.020791
MonoIsotopic Mass: 235.020791
Topological Polar Surface Area: 29.5 
Canonical SMILES: CN1CCC=C(C1)C(=O)OC.Br
InChI: InChI=1S/C8H13NO2.BrH/c1-9-5-3-4-7(6-9)8(10)11-2;/h4H,3,5-6H2,1-2H3;1H
InChIKey: AXOJRQLKMVSHHZ-UHFFFAOYSA-N
EINECS: 206-087-3
Product Categories: Heterocyclic Compounds; Pyridine Alkaloids; Alkaloids; Biochemistry;Esters; Pyridines

Arecoline hydrobromide Toxicity Data With Reference

frog LD50 parenteral 160mg/kg (160mg/kg)   Acta Biologica et Medica Germanica. Vol. 28, Pg. 681, 1972.
mouse LD50 intravenous 18mg/kg (18mg/kg)   U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. Vol. NX#11778,
mouse LD50 oral 600mg/kg (600mg/kg)   United States Patent Document. Vol. #4921868,
mouse LDLo subcutaneous 65mg/kg (65mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 35, Pg. 75, 1929.
rat LD50 parenteral 270mg/kg (270mg/kg)   Acta Biologica et Medica Germanica. Vol. 28, Pg. 681, 1972.

Arecoline hydrobromide Safety Profile

Hazard Codes: HarmfulXn, ToxicT
Risk Statements: 22-23/24/25 
R22:Harmful if swallowed. 
R23/24/25:Toxic by inhalation, in contact with skin and if swallowed.
Safety Statements: 45-38-36/37/39-28A 
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) 
S38:In case of insufficient ventilation, wear suitable respiratory equipment. 
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection. 
S28:After contact with skin, wash immediately with plenty of soap-suds.
WGK Germany: 3
RTECS: QT2275000
F: 8
HS Code: 29399990
Poison by parenteral, subcutaneous, and intravenous routes. When heated to decomposition it emits very toxic fumes of HBr and NOx.

Arecoline hydrobromide Specification

 Arecoline hydrobromide (CAS NO.300-08-3) is also named as Arecoline bromide ; Arekolinhydrobromid ; Arekolinhydrobromid [German] ; Methyl 1,2,5,6-tetrahydro-1-methylnicotinate, hydrobromide ; Methyl N-methyl-1,2,5,6-tetrahydronicotinate hydrobromide ; N-Methyltetrahydronicotinic acid methyl ester hydrobromide ; NSC 31750 ; Taeniolin ; UNII-24S79B9CX7 . It is white fine powder. Arecoline hydrobromide (CAS NO.300-08-3) is highly toxic. It is flammable. It will produce toxic nitrogen oxide and hydrogen bromide fumes when buring. So the storage environment should be ventilate, low-temperature and dry. Keep Arecoline hydrobromide (CAS NO.300-08-3) separate from raw materials of food.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View